IL2 and glioblastoma: Type I NKT cells mediate killing on CD1d-positive GBM cell lines or CD1d-positive patient-derived GBM cells after the NKT cells are expanded with IL-2 and α-GalCer (KRN7000, a synthetic glycosphingolipid originally isolated from a marine sponge).